Fusion Antibodies News

News

Studies prove antigens created by Fusion Antibodies accurately identify SARS-CoV-2

Fusion Antibodies have leveraged their antigen expertise to create multiple antigens to be used against the COVID-19 pandemic.
News

Dr McGirr named ‘Future Innovator’ Winner at KTP Best of the Best Awards

Dr Leona McGirr of Fusion Antibodies has received a top honour at the annual celebration of the most outstanding Knowledge Transfer Partnership (KTP) Projects.
News

Fusion Antibodies collaborates with QUB Led Project in Multi-Million Pound Funding Bid

A Belfast-based bid led by Queens University Belfast (QUB), is the only bid from Northern Ireland to be selected for the next stage of the UK Research and Innovation’s Strength in Places Fund (SIPF).
News

Fusion Antibodies make key Covid-19 Reagents available

As part of our efforts to combat the Covid-19 pandemic, We have designed and expressed a panel of unique recombinant protein antigens to assist in the search for a neutralising therapeutic antibody against SARS-CoV 2. ​
News

Fusion Antibodies partner with BioTickle to deliver antibody development services in India

Fusion Antibodies have named BioTickle as their exclusive distributor in India to provide access to proprietary antibody discovery, engineering and cell line development technologies.
News

Research Alliance with Queen’s University Belfast

A new research alliance has been formed to seek new therapeutic and diagnostic approaches to help in the global fight against the coronavirus pandemic.
News

Fusion Antibodies update regarding COVID-19 business continuity.

Update on the Coronavirus / COVID-19 situation.
News

Fusion Antibodies Collaborates with Queen’s University on Knowledge Transfer Partnership Programme

The new programme will allow for the development of an innovative software solution for the design of antibody libraries.
News

Fusion Antibodies form strategic collaboration with E2DG to provide end-to-end service for oncology drug discovery companies.

The two companies will work together to deliver a seamless service offering for clients from discovery to manufacturing and PoC preclinical and phase I & II design and execution.
News

Fusion Antibodies celebrates Antibody Humanization Milestone

Fusion Antibodies, a world leading CRO, has today announced that they have successfully completed their 150th Antibody Humanization project as part of their Antibody Engineering offering
News

Fusion Antibodies launches Affinity Maturation Service

Fusion Antibodies introduces novel Affinity Maturation platform (RAMP™).
News

Fusion Antibodies partner with Erada to develop ground breaking Malaria diagnostic

Ground Breaking New Saliva Diagnostic Test Set to Help Eliminate Malaria.